Kura Oncology's total assets for Q1 2026 were $652.55M, a decrease of -11.62% from the previous quarter. KURA total liabilities were $544.67M for the fiscal quarter, a -3.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.